Weijiang Zhang
Overview
Explore the profile of Weijiang Zhang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
54
Citations
380
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yang J, Yu Z, Li S, Zhang W, He J, Qu X, et al.
Phytochem Anal
. 2024 Nov;
PMID: 39540423
Background: Ginseng volatile oil (GVO) is a valuable active ingredient in ginseng (Panax ginseng C. A. Mey.) with high research potential. Drying procedures alter the real composition of the fresh...
2.
Gao J, Fan W, Zhang W, Fan Y, Xu H
J Foot Ankle Surg
. 2024 Aug;
63(6):731-734.
PMID: 39098650
Open ankle fractures, especially Gustilo-Anderson type III fractures are challenging to manage with controversy over the "best" or "superior" treatment strategy. This study aimed to evaluate the treatment outcome of...
3.
Feng N, Huang Y, Tian J, Wang Y, Ma Y, Zhang W
Sci Rep
. 2024 Apr;
14(1):9269.
PMID: 38649378
Rainwater is the main water source in arid and semiarid areas of the Loess Plateau, where rainfall is generally insufficient, ineffective and underutilized during the growing season. Thus, improving rainwater...
4.
Li T, Zhang W, Niu M, Wu Y, Deng X, Zhou J
Front Immunol
. 2024 Mar;
15:1342647.
PMID: 38550593
Background: Cervical cancer poses a significant global threat to women's health. However, current therapeutic interventions, such as radiotherapy, chemotherapy, surgical resection, and immune checkpoint inhibitors, face limitations in the advanced...
5.
Li T, Niu M, Zhang W, Qin S, Zhou J, Yi M
Front Immunol
. 2024 Feb;
15:1361194.
PMID: 38404574
Natural Killer (NK) cells, intrinsic to the innate immune system, are pivotal in combating cancer due to their independent cytotoxic capabilities in antitumor immune response. Unlike predominant treatments that target...
6.
Li J, Liu K, Hu Y, Zhang H, Heidari A, Chen H, et al.
Comput Biol Med
. 2023 Jan;
158:106501.
PMID: 36635120
Computerized tomography (CT) is of great significance for the localization and diagnosis of liver cancer. Many scholars have recently applied deep learning methods to segment CT images of liver and...
7.
Wang X, You L, Zhang W, Ma Y, Tang Y, Xu W
Photodiagnosis Photodyn Ther
. 2022 Mar;
38:102807.
PMID: 35288319
Background: The treatment options for low-grade squamous intraepithelial neoplasia (LSIL) of the cervix with high-risk HPV infection have not been standardized. Studies show that photodynamic therapy (PDT) mediated by 5-aminolevulinic...
8.
Zhang W, Mathisen M, Goodman G, Forbes H, Song Y, Bertran E, et al.
Clin Pharmacol Drug Dev
. 2020 Jul;
10(1):39-45.
PMID: 32602215
The effects of itraconazole, a strong CYP3A4 inhibitor, on the steady-state pharmacokinetics of vemurafenib were evaluated in a phase 1, multicenter, open-label, fixed-sequence study. Patients with BRAF mutation-positive metastatic malignancies...
9.
Li H, Zhang W, Petry C, Li L, Fernandez E, Kiialainen A, et al.
Clin Pharmacol Drug Dev
. 2020 May;
10(1):30-38.
PMID: 32433829
This phase 1, open-label, single-center study evaluated the pharmacokinetics (PK), pharmacodynamics, safety, and tolerability of single-dose emicizumab in healthy Chinese males. Overall, 16 subjects received a single subcutaneous dose of...
10.
Zhang W, McIntyre C, Riehl T, Forbes H, Bertran E, Choi H, et al.
Clin Pharmacol Drug Dev
. 2020 Apr;
9(5):651-658.
PMID: 32311241
This phase 1 open-label, multicenter, 3-period, fixed-sequence study evaluated the effect of multiple doses of vemurafenib on the pharmacokinetics of 1 dose of tizanidine, a probe CYP1A2 substrate, in patients...